Please login to the form below

Not currently logged in
Email:
Password:

Envigo

This page shows the latest Envigo news and features for those working in and with pharma, biotech and healthcare.

Latest appointments

  • Lynn Lewis joins Envigo Lynn Lewis joins Envigo

    She becomes the CRO’s senior vice president of global sales. Envigo, a contract research organisation, has appointed Lynn Lewis to the position of senior vice president of global sales, a ... Dr Adrian Hardy, president and chief executive officer of

  • Envigo appoints Lizanne Muller as president, EMEA operations Envigo appoints Lizanne Muller as president, EMEA operations

    Contract research organisation Envigo has appointed Lizanne Muller as president of its EMEA operations. ... In her new role Muller will be accountable for Envigo’s contract research services and research services models operations across Europe and Asia

  • Envigo appoints Dr Adrian Hardy as president and CEO Envigo appoints Dr Adrian Hardy as president and CEO

    firm. Prior to joining Envigo, Dr Hardy was a product development manager for Novartis, and served as a director at law firm iPulse. ... Dr Hardy said: “I'm delighted and extremely proud to be taking on this role at such an exciting time for Envigo and

  • Envigo appoints Patricia Henahan as chief financial officer Envigo appoints Patricia Henahan as chief financial officer

    She brings experience from AZ, Eli Lilly and Hospira. Research company Envigo - formerly known as Huntindon Life Sciences - has appointed Patricia Henahan as its new chief financial officer. ... Brian Cass, chief executive officer at Envigo, said: “I

More from appointments
Approximately 4 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics